Free Trial

G1 Therapeutics (GTHX) SEC Filings & 10K Form

$7.13
0.00 (0.00%)
(As of 09/6/2024 ET)

Recent G1 Therapeutics SEC Filings

DateFilerForm TypeView
09/05/2024
7:02 AM
G1 Therapeutics (Subject)
Form SC 14D9/A
09/05/2024
6:32 AM
G1 Therapeutics (Subject)
Pharmacosmos A/S (Filed by)
Form SC TO-T/A
08/20/2024
2:40 PM
G1 Therapeutics (Subject)
Form SC 14D9
08/20/2024
2:24 PM
G1 Therapeutics (Subject)
Pharmacosmos A/S (Filed by)
Form SC TO-T
08/19/2024
6:02 PM
Beryl Capital Management LLC (Filed by)
G1 Therapeutics (Subject)
Form SC 13G
08/14/2024
3:33 PM
G1 Therapeutics (Subject)
Pharmacosmos A/S (Filed by)
Form SC TO-C
08/08/2024
5:54 AM
G1 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
4:30 PM
G1 Therapeutics (Subject)
Pharmacosmos A/S (Filed by)
Form SC TO-C
08/07/2024
4:03 PM
G1 Therapeutics (Subject)
Form SC14D9C
08/07/2024
4:10 PM
G1 Therapeutics (Subject)
Form SC14D9C
08/07/2024
8:21 AM
G1 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2024
4:53 PM
Bailey John E. Jr. (0001806147) (Reporting)
G1 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
4:54 PM
G1 Therapeutics (Issuer)
Umstead John W. V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
4:55 PM
Avagliano Mark (Reporting)
G1 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
4:57 PM
G1 Therapeutics (Issuer)
Malik Rajesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
4:58 PM
G1 Therapeutics (Issuer)
MURDOCK TERRY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2024
4:59 PM
G1 Therapeutics (Issuer)
Perry Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
4:32 PM
G1 Therapeutics (Issuer)
MURDOCK TERRY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
4:34 PM
G1 Therapeutics (Issuer)
Perry Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
4:22 PM
Bailey John E. Jr. (0001806147) (Reporting)
G1 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
4:24 PM
G1 Therapeutics (Issuer)
Umstead John W. V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
4:26 PM
Avagliano Mark (Reporting)
G1 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
4:27 PM
G1 Therapeutics (Issuer)
Thomas Monica R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
5:35 AM
G1 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
3:37 PM
G1 Therapeutics (Issuer)
Nicholson Garry A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:39 PM
Flowers Cynthia Louise (Reporting)
G1 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:40 PM
G1 Therapeutics (Issuer)
Lee Jacks (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:41 PM
G1 Therapeutics (Issuer)
MUIR GLENN P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:42 PM
G1 Therapeutics (Issuer)
Secor Alicia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:43 PM
G1 Therapeutics (Issuer)
Sharpless Norman (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2024
5:38 AM
G1 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/12/2024
3:12 PM
G1 Therapeutics (Filer)
Form PRE 14A
04/09/2024
3:29 PM
G1 Therapeutics (Subject)
Velleca Mark A. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2024
3:32 PM
G1 Therapeutics (Issuer)
Umstead John W. V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
5:35 AM
G1 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2024
5:14 PM
G1 Therapeutics (Issuer)
Malik Rajesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
2:37 PM
Fisher Asset Management, LLC (Filed by)
G1 Therapeutics (Subject)
Form SCHEDULE 13G
01/09/2024
3:19 PM
G1 Therapeutics (Subject)
Velleca Mark A. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
5:30 AM
G1 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
5:00 AM
G1 Therapeutics (Issuer)
MURDOCK TERRY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
5:02 AM
Avagliano Mark (Reporting)
G1 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Kamala’s Dirty Election Move… Revealed (Ad)

According to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppet masters are planning this dirty election move…

Click here now and learn how to prepare.
01/08/2024
5:02 AM
Bailey John E. Jr. (0001806147) (Reporting)
G1 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
5:03 AM
G1 Therapeutics (Issuer)
Perry Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
5:03 AM
G1 Therapeutics (Issuer)
Malik Rajesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
5:03 AM
G1 Therapeutics (Issuer)
Thomas Monica R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
5:04 AM
G1 Therapeutics (Issuer)
Umstead John W. V (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
6:44 PM
Bailey John E. Jr. (0001806147) (Reporting)
G1 Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
3:45 PM
G1 Therapeutics (Issuer)
Malik Rajesh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
3:40 PM
G1 Therapeutics (Subject)
Velleca Mark A. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2023
5:43 PM
G1 Therapeutics (Subject)
Malik Rajesh (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/01/2023
3:37 PM
G1 Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/01/2023
5:46 AM
G1 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/21/2023
3:15 PM
G1 Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:GTHX) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners